Anticonvulsant actions of nefiracetam on epileptic EL mice and their relation to peripheral-type benzodiazepine receptors

Brain Research

Volumn 859, Issue 2, 2000, Pages 255-261

  Shiotani, Tadashi ^a,b   Nakamoto, Yurie ^c   Watabe, Shigeo ^b,c   Yoshii, Mitsunobu ^c   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Tokyo Research and Development Center   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Anticonvulsant; EL mouse; Epilepsy; Nefiracetam; Peripheral type benzodiazepine receptor; Ro 5 4864

Indexed keywords

4' CHLORODIAZEPAM; ANIRACETAM; BENZODIAZEPINE RECEPTOR; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NEFIRACETAM; NOOTROPIC AGENT; OXIRACETAM; PIRACETAM;

ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG RECEPTOR BINDING; EPILEPSY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

ANIMALS; ANTICONVULSANTS; BENZODIAZEPINONES; CONVULSANTS; DISEASE MODELS, ANIMAL; EPILEPSY; MALE; MICE; MICE, INBRED STRAINS; NOOTROPIC AGENTS; PYRROLIDINONES; RADIOLIGAND ASSAY; RECEPTORS, GABA-A; SEIZURES;

EID: 0034708710     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)01971-5     Document Type: Article

References (38)

1. R.R. Anholt, P.L. Pedersen, S.E. De, S.H. Snyder, The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane, J. Biol. Chem. 261 (1986) 576-583.
2. E.E. Baulieu, P. Robel, Neurosteroids: a new brain function?, J. Steroid Biochem. Mol. Biol. 37 (1990) 395-403.
3. J. Bénavidès, F. Guilloux, D.E. Allam, A. Uzan, J. Mizoule, C. Renault, M.C. Dubroeucq, C. Guérémy, G. Le Fur, Opposite effects of an agonist, RO5-4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA/2J mice, Life Sci. 34 (1984) 2613-2620.
4. A.S. Bender, L. Hertz, Flunitrazepam binding to intact and homogenized astrocytes and neurons in primary cultures, J. Neurochem. 43 (1984) 1319-1327.
5. A.C. Bowling, R.J. DeLorenzo, Micromolar affinity benzodiazepine receptors: identification and characterization in central nervous system, Science 216 (1982) 1247-1250.
6. I. Duels, L.O. Norenberg, M.D. Norenberg, The benzodiazepine receptor in cultured astrocytes from genetically epilepsy-prone rats, Brain Res 531 (1990) 318-321.
7. W. Fröstl, L. Maître, The families of cognition enhancers, Pharmacopsychiatry 22 (1989) 54-100.
8. K.F. Funk, J. Schmidt, Changes of dopamine metabolism by hypoxia and effect of nootropic drugs, Biomed. Biochem. Acta 11 (1984) 1301-1304.
9. M.G. Giovannini, P. Rodino, D. Muttolo, G. Pepeu, Oxiracetam and aniracetam increase acetylcholine release from the rat hippocampus in vivo, Drug Dev. Res. 28 (1993) 503-509.
10. C.E. Giurgea, The nootropic concept and its prospective implications, Drug Dev. Res. 2 (1982) 441-446.
11. A.H. Gouliaev, A. Senning, Piracetam and other structurally related nootropics, Brain Res. Rev. 19 (1994) 180-222.
12. A.J. Gower, M. Noyer, R. Verloes, J. Gobert, E. Wülfert, ucb L059, a novel anti-convulsant drug: pharmacological profile in animals, Eur. J. Pharmacol. 222 (1992) 193-203.
13. C. Hariton, L. Ciesielski, J.P. Cano, P. Mandel, Studies on benzodiazepine receptor subtypes in a model of chronic spontaneous petit mal-like seizures, Neurosci. Lett. 84 (1988) 97-102.
14. C.A. Hawkins, J.H. Mellandy, Piracetam potentiates the antiepileptic action of carbamazepine in chronic experimental limbic epilepsy, Acta Neurol. Scand. 74 (1986) 117-121.
15. A receptor-channel complex in dorsal root ganglion neurons, Neuropharmacology 35 (1996) 1251-1261.
16. J.T.J. King, C.C. LaMotte, El mouse as a model of focal epilepsy: a review, Epilepsia 30 (1989) 257-265.
17. K.W. Kinnally, D.B. Zorov, Y.N. Antonenko, S.H. Snyder, M.W. McEnery, H. Tedeschi, Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 1374-1378.
18. Y. Kitano, M. Makino, C. Usui, K. Takasuna, Y. Kasai, M. Hirohashi, K. Tamura, S. Takayama, H. Kojima, H. Iizuka, T. Yanagita, General pharmacological profile of the new cognition-enhancing agent nefiracetam, Arzneim.-Forsch. 44 (1994) 199-210.
19. K.E. Kreuger, Peripheral-type benzodiazepine receptor: a second site of action for benzodiazepines, Neuropsychopharmacology 4 (1991) 237-244.
20. O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, Protein measurement with the folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
21. M. Marchi, E. Besana, M. Raiteri, Oxiracetam increases the release of endogenous glutamate from depolarized rat hippocampal slices, Eur. J. Pharmacol. 185 (1990) 247-249.
22. T. Nabeshima, Y. Noda, K. Tohyama, J. Itoh, T. Kameyama, Effects of DM-9384 in a model of amnesia based on animals with GABAergic neuronal dysfunctions, Eur. J. Pharmacol. 178 (1990) 143-149.
23. Y. Nakamoto, S. Watabe, T. Shiotani, M. Yoshii, Peripheral-type benzodiazepine receptors in association with epileptic seizures in EL mice, Brain Res. 717 (1996) 91-98.
24. Y. Nakamoto, M. Yoshii, Inhibition of the proconvulsive action of peripheral-type benzodiazepine receptors by nootropic agents in El mice, Soc. Neurosci. Abstr. 19 (1993) 394.
25. Y. Nakamoto, M. Yoshii, S. Watabe, T. Shiotani, Peripheral-type benzodiazepine receptor as a site of anticonvulsant action of nootropic agents, Neurosci. Res. Suppl. 18 (1993) S51.
26. T. Nishizaki, T. Matsuoka, T. Nomura, S. Matsuyama, S. Watabe, T. Shiotani, M. Yoshii, A "long-term-potentiation-like" facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam, Brain Res. 826 (1999) 281-288.
27. T. Nishizaki, T. Matsuoka, T. Nomura, K. Sumikawa, T. Shiotani, S. Watabe, M. Yoshii, Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways, Mol. Pharmacol. 53 (1998) 1-5.
28. M. Noyer, M. Gillard, A. Matagne, J.-P. Henichart, E. Wülfert, The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes, Eur. J. Pharmacol. 286 (1995) 137-146.
29. M. Oyaizu, T. Narahashi, Modulation of the neuronal nicotinic acetylcholine receptor-channel by the nootropic drug nefiracetam, Brain Res. 822 (1999) 72-79.
30. M. Sarter, Taking stock of cognition enhancers, Trends Pharmacol. Sci. 12 (1991) 456-461.
31. 3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striaturn and Huntington's diseased basal ganglia, Brain Res. 248 (1982) 396-401.
32. J. Suzuki, Y. Nakamoto, Seizure patterns and electroencephalograms of El mouse, Electroencephalogr. Clin. Neurophysiol. 43 (1977) 299-311.
33. S. Watabe, H. Yamaguchi, S. Ashida, DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex, Eur. J. Pharmacol. 238 (1993) 303-309.
34. S. Watabe, M. Yoshii, N. Ogata, A. Tsunoo, T. Narahashi, Differential inhibition of transient and long-lasting calcium channel currents by benzodiazepines in neuroblastoma cells, Brain Res. 606 (1992) 244-250.
35. 3H]Ro 5-4864, a convulsant benzodiazepine, to guinea pig brain, J. Neurochem. 42 (1984) 969-975.
36. K. Yamada, T. Nabeshima, Nefiracetam (DM-9384): a novel antiamnesic drug, CNS Drug Rev. 2 (1996) 322-342.
37. M. Yoshii, S. Watabe, Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells, Brain Res. 642 (1994) 123-131.
38. D.M. Zisterer, D.C. Williams, Peripheral-type benzodiazepine receptors, Gen. Pharmacol. 29 (1997) 305-314.